SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000918066-03-000013
Filing Date
2003-12-23
Accepted
2003-12-23 11:30:12
Documents
1
Period of Report
2003-12-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT c0000938746d20031223f4f.html 4  
1 PRIMARY DOCUMENT c0000938746d20031223f4f.xml 4 10175
  Complete submission text file 0000918066-03-000013.txt   11914
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3801 CANTERBURY RD 1102 BALTIMORE MD 21218
Business Address 3801 CANTERBURY RD 1102 BALTIMORE MD 21218 4109553024
SNYDER SOLOMON H MD (Reporting) CIK: 0000938746 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23736 | Film No.: 031069866